Changchun BCHT Biotechnology Co. (SHA:688276)
China
· Delayed Price · Currency is CNY 20.76
+0.03 (0.14%)
May 23, 2025, 2:45 PM CST
SHA:688276 Revenue
In the year 2024, Changchun BCHT Biotechnology Co. had annual revenue of 1.23B CNY, down -32.64%. Changchun BCHT Biotechnology Co. had revenue of 162.29M in the quarter ending March 31, 2025, a decrease of -39.96%.
Revenue
1.23B
Revenue Growth
-32.64%
P/S Ratio
6.98
Revenue / Employee
990.40K
Employees
1,241
Market Cap
8.58B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |